Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Proliferating patterns of salivary gland adenocarcinomas with the use of PCNA labeling.

Zhao M, Zhao QX, Saitoh M, Ohmura H, Okamoto Y, Shrestha P, Mori M.

Anticancer Res. 1996 Sep-Oct;16(5A):2693-8.

PMID:
8917372
2.

The cribriform features of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma: cytokeratin and integrin expression.

Araújo VC, Loducca SV, Sousa SO, Williams DM, Araújo NS.

Ann Diagn Pathol. 2001 Dec;5(6):330-4.

PMID:
11745070
3.
4.

Polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma: a review and comparison of immunohistochemical markers.

Darling MR, Schneider JW, Phillips VM.

Oral Oncol. 2002 Oct;38(7):641-5. Review.

PMID:
12167416
5.

Adenoid cystic carcinoma with high-grade transformation: a report of 11 cases and a review of the literature.

Seethala RR, Hunt JL, Baloch ZW, Livolsi VA, Leon Barnes E.

Am J Surg Pathol. 2007 Nov;31(11):1683-94. Review.

PMID:
18059225
6.

Evaluation of the nucleolar organizer region associated proteins in minor salivary gland tumors.

van Heerden WF, Raubenheimer EJ.

J Oral Pathol Med. 1991 Jul;20(6):291-5. Review.

PMID:
1716320
7.

Hyaluronan and CD44 expression in minor salivary gland tumors.

Xing R, Regezi JA, Stern M, Shuster S, Stern R.

Oral Dis. 1998 Dec;4(4):241-7.

PMID:
10200702
8.

Correlation of human Bub1 expression with tumor-proliferating activity in salivary gland tumors.

Shigeishi H, Yoneda S, Taki M, Nobumori T, Ohta K, Higashikawa K, Yasui W, Kamata N.

Oncol Rep. 2006 Apr;15(4):933-8.

PMID:
16525682
9.

[Myoepithelial differentiation markers in salivary gland neoplasia].

Scarpellini F, Marucci G, Foschini MP.

Pathologica. 2001 Dec;93(6):662-7. Italian.

PMID:
11785118
11.

Metallothionein immunostaining in adenoid cystic carcinomas of the salivary glands.

Alves SM, Cardoso SV, de Fátima Bernardes V, Machado VC, Mesquita RA, Vieira do Carmo MA, Ferreira Aguiar MC.

Oral Oncol. 2007 Mar;43(3):252-6. Epub 2006 Jul 20.

PMID:
16857408
12.

Proliferative activity in oral salivary gland tumors: the role of PCNA and AgNOR assessed by a double staining technique.

Rivero ER, Caliari MV, Tarquínio SB, Loyola AM, de Aguiar MC.

J Oral Sci. 2004 Jun;46(2):87-92.

13.

The evaluation of salivary gland tumours using proliferating cell nuclear antigen.

Trendell-Smith NJ, Oates J, Crocker J.

J Laryngol Otol. 1997 Jun;111(6):551-5.

PMID:
9231090
14.

Differential expression of galectin-3, beta-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands.

Ferrazzo KL, Neto MM, dos Santos E, dos Santos Pinto D, de Sousa SO.

J Oral Pathol Med. 2009 Oct;38(9):701-7. doi: 10.1111/j.1600-0714.2009.00776.x. Epub 2009 Jul 31.

PMID:
19659475
15.

Polymorphous low-grade adenocarcinoma of minor salivary gland. A comparative histologic and immunohistochemical study.

Regezi JA, Zarbo RJ, Stewart JC, Courtney RM.

Oral Surg Oral Med Oral Pathol. 1991 Apr;71(4):469-75.

PMID:
1711187
17.

Selective immunohistochemical comparison of polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma.

Beltran D, Faquin WC, Gallagher G, August M.

J Oral Maxillofac Surg. 2006 Mar;64(3):415-23.

PMID:
16487803
18.

Actin versus vimentin in myoepithelial cells of salivary gland tumors. A comparative study.

de Araujo VC, Carvalho YR, de Araujo NS.

Oral Surg Oral Med Oral Pathol. 1994 Apr;77(4):387-91.

PMID:
8015803
19.

Assessment of proliferating cell nuclear antigen immunostaining in parotid tumors.

Takahashi M, Adachi T, Matsui R, Miyokawa N.

Eur Arch Otorhinolaryngol. 1998;255(6):311-4.

PMID:
9693928
20.

Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.

Shintani S, Mihara M, Nakahara Y, Kiyota A, Yoshihama Y, Ueyama Y, Matsumura T.

Anticancer Res. 2000 May-Jun;20(3B):2169-75.

PMID:
10928172

Supplemental Content

Support Center